Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1983 Jun;80(12):3753–3757. doi: 10.1073/pnas.80.12.3753

Analysis of two-dimensional protein patterns from mouse embryos with different trisomies.

J Klose, B Putz
PMCID: PMC394129  PMID: 6574515

Abstract

Two-dimensional protein patterns from whole mouse embryos with different trisomies (Ts) (Ts1, -12, -14, -19) and from different organs (normal or malformed) and developmental stages of Ts12 embryos were analyzed by comparison with control patterns. Quantitatively altered proteins were found, and a portion of these (21/approximately equal to 1,000, average) was attributable to the Ts conditions. Most of these variants were found always (regularly) in Ts embryos. They could be divided into two groups: group I shows characteristics (chromosome specific, density increased by a factor close to 1.5 +/- 0.12) compatible with proteins directly affected by the Ts; and group II (chromosome nonspecific, density decreased, seldom increased) results most likely from indirect effects. The incidence of group II variants (about 13/approximately equal to 1,000, average) was considerably greater than that of the group I variants (about 3/approximately equal to 1,000). The frequency of both types of variants, however, was far lower than was expected by a rough estimation. Apparently, a relatively small number of changes, rather than a complex, escalating effect, was induced at the protein level by the Ts. Some observations suggest that this is due to a stable regulation of protein concentrations. The proportion in which quantitative changes of different types occurred in the protein patterns did not correlate with the degree of developmental impairments (malformation, retardation, early death) of the embryos. The generalized occurrence of protein changes on the cellular level might explain the restricted viability of Ts mouse embryos.

Full text

PDF
3753

Images in this article

3754Image
on p.3754

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Britten R. J., Davidson E. H. Gene regulation for higher cells: a theory. Science. 1969 Jul 25;165(3891):349–357. doi: 10.1126/science.165.3891.349. [DOI] [PubMed] [Google Scholar]
  2. Brown W. T., Dutkowski R., Darlington G. J. Localization and quantitation of human superoxide dismutase using computerized 2-D gel electrophoresis. Biochem Biophys Res Commun. 1981 Sep 30;102(2):675–681. doi: 10.1016/s0006-291x(81)80185-4. [DOI] [PubMed] [Google Scholar]
  3. CRIPPA M. THE MOUSE KARYOTYPE IN SOMATIC CELLS CULTURED IN VITRO. Chromosoma. 1964 Aug 14;15:301–311. doi: 10.1007/BF00321516. [DOI] [PubMed] [Google Scholar]
  4. Epstein C. J., Epstein L. B., Cox D. R., Weil J. Functional implications of gene dosage effects in trisomy 21. Hum Genet Suppl. 1981;2:155–172. doi: 10.1007/978-3-642-68006-9_12. [DOI] [PubMed] [Google Scholar]
  5. Epstein C. J., Tucker G., Travis B., Gropp A. Gene dosage for isocitrate dehydrogenase in mouse embryos trisomic for chromosome 1. Nature. 1977 Jun 16;267(5612):615–616. doi: 10.1038/267615a0. [DOI] [PubMed] [Google Scholar]
  6. Gropp A., Kolbus U. Exencephaly in the syndrome of trisomy no. 12 of the foetal mouse. Nature. 1974 May 10;249(453):145–147. doi: 10.1038/249145a0. [DOI] [PubMed] [Google Scholar]
  7. Gropp A., Kolbus U., Giers D. Systematic approach to the study of trisomy in the mouse. II. Cytogenet Cell Genet. 1975;14(1):42–62. doi: 10.1159/000130318. [DOI] [PubMed] [Google Scholar]
  8. Gropp A., Putz B., Zimmermann U. Autosomal monosomy and trisomy causing developmental failure. Curr Top Pathol. 1976;62:177–192. doi: 10.1007/978-3-642-66458-8_12. [DOI] [PubMed] [Google Scholar]
  9. Klose J., Feller M. Genetic variability of proteins from plasma membranes and cytosols of mouse organs. Biochem Genet. 1981 Oct;19(9-10):859–870. doi: 10.1007/BF00504251. [DOI] [PubMed] [Google Scholar]
  10. Klose J. Genetic variability of soluble proteins studied by two-dimensional electrophoresis on different inbred mouse strains and on different mouse organs. J Mol Evol. 1982;18(5):315–328. doi: 10.1007/BF01733898. [DOI] [PubMed] [Google Scholar]
  11. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik. 1975;26(3):231–243. doi: 10.1007/BF00281458. [DOI] [PubMed] [Google Scholar]
  12. Klose J., Zeindl E., Sperling K. Analysis of protein patterns in two-dimensional gels of cultured human cells with trisomy 21. Clin Chem. 1982 Apr;28(4 Pt 2):987–992. [PubMed] [Google Scholar]
  13. Klose J., von Wallenberg-Pachaly H. Changes of soluble protein populations during organogenesis of mouse embryos as revealed by protein mapping. Dev Biol. 1976 Jul 15;51(2):324–331. doi: 10.1016/0012-1606(76)90147-0. [DOI] [PubMed] [Google Scholar]
  14. O'Farrell P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975 May 25;250(10):4007–4021. [PMC free article] [PubMed] [Google Scholar]
  15. Putz B., Krause G., Garde T., Gropp A. A comparison between trisomy 12 and vitamin A induced exencephaly and associated malformations in the mouse embryo. Virchows Arch A Pathol Anat Histol. 1980;386(1):65–80. doi: 10.1007/BF00432645. [DOI] [PubMed] [Google Scholar]
  16. Weil J., Epstein C. J. The effect of trisomy 21 on the patterns of polypeptide synthesis in human fibroblasts. Am J Hum Genet. 1979 Jul;31(4):478–488. [PMC free article] [PubMed] [Google Scholar]
  17. Zuckerkandl E. Multilocus enzymes, gene regulation, and genetic sufficiency. J Mol Evol. 1978 Oct 27;12(1):57–89. doi: 10.1007/BF01732545. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES